..., quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements. 2024 Adjuvant therapy Immunotherapy Renal cell carcinoma Real-world data...

... was 67.1 ± 9.1 (ranging from 49.3 to 84.9) months. The average relapse-free survival was 48.8 ± 9.9 (ranging from 29.5 to 68.2) months. Six patients received adjuvant therapy, mainly chemotherapy. Five patients died during follow-up. Conclusions: Early physical examination may be helpful for early...

... stage Positive surgical margin Adjuvant therapy Fig. 2. The resected specimen of umbilical, urachus, and urachal carcinoma. Fig. 2. The resected specimen of umbilical, urachus, and urachal carcinoma. Fig. 3. a Urachal adenocarcinoma, mucinous type. b Urachal adenocarcinoma...

... and efficacy of this device were investigated as adjuvant therapy to first-line antimicrobials for treatment of uncomplicated urinary tract infection (UTI) in adults. Patients and Methods: In this multicentre, randomised, parallel group, double-blind, phase IV study, xyloglucan + gelose ( n = 20) or placebo...